Arana Therapeutics
HOME

Archive News

2009 |2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002

To download and view any of the documents listed below, click on the links. To view or print the Portable Document Format (PDF) files, you will need Adobe Acrobat Viewer installed on your system.

If you do not have the latest Adobe Viewer, please download it here before you attempt to open the desired file.

2003    
December 18, 2003 Formal Resolution to Abbott Dispute  
December 11, 2003 Domantis - Dual Targeting dAbs  
December 6, 2003 Joint Venture with Biosceptre  
December 3, 2003 Resolution to Abbott Dispute  
December 3, 2003 New Director  
November 21, 2003 New Ovuplant® European distributor  
November 5, 2003 Abbott ASX2  
October 30, 2003 Centocor Arbitration  
September 17, 2003 Suprelorin® Australian approval  
September 12, 2003 Humira European Approval  
September 11, 2003 August 03 Presentation  
August 21, 2003 MD Retirement  
August 21, 2003 Domantis Presentation  
August 1, 2003 Domantis and EvoGenix to collaborate  
July 10, 2003 Media Release Half Year Report  
July 5, 2003 Domantis pre-clinical  
July 3, 2003 Suprelorin® NZ Approval  
July 1, 2003 Humira Announcement
June 24, 2003 Domantis-ImClone  
June 14, 2003 Anti-TNF FDA  
June 14, 2003 Centocor update  
May 30, 2003 Scios-469  
May 27, 2003 EvoGenix Pty Limited announced today that it had been awarded an Australian Federal Government START grant of $900,000 to support its therapeutics development program over the next two years  
May 15, 2003 Chairman's Presentation  
May 14, 2003 Centocor Update  
May 3, 2003 Peptech AGM 2003 Follow-Up  
April 23, 2003 Peptech AGM 2003 Presentation  
April 16, 2003 Chairman's AGM Address  
April 13, 2003 EvoGenix announces collaboration with New Zealand’s Genesis Research and Development Corporation, to jointly develop anti-inflammatory drugs against a novel immunomodulator target  
April 11, 2003 MD's AGM Address  
April 10, 2003 Peptech anti-TNF domain antibodies to enter pre-clinical studies and Peptech Domantis early payment  
April 3, 2003 Domantis Press Release on Grant of Patent  
March 4, 2003 Domantis Holmes appointment  
March 1, 2003 ASX Query  
February 27, 2003 Peptech Announces Share Placement  
February 22, 2003 Abbott Humira USA approval  
February 22, 2003 Peptech US Anti TNF Patent 6498237 issued  
February 20, 2003 EvoGenix has announced the appointment of antibody engineering pioneer Dr Hennie Hoogenboom as an adviser to the company  
January 16, 2003 EvoGenix announces grant of key patent in the USA – “Patent grant gives marketing edge”